To ATCC Valued Customers,

ATCC stands ready to support our customers’ needs during the coronavirus pandemic. If you experience any issues with your products or services, please contact ATCC Customer Service at For Technical questions please contact Thank you.

Privacy Policy Update

We remain dedicated to protecting your data and experience throughout our platforms. We have updated our Privacy Policy and your continued use of the Site means you have accepted the revised Privacy Policy. View now >


FAQ Home

Find Answers

IDH2 mutant-TF-1 Isogenic Cell Line ATCC CRL-2003IG

What type of mutation does the IDH2 mutant-TF-1 Isogenic Cell Line (ATCC® CRL-2003IG ™) contain and how was this line created?  

ATCC® CRL-2003IG ™ contains a homozygous knock-in mutation at position c.419G>A, p.R140Q generated from the parental TF-1 (ATCC® CRL-2003) human acute myeloid leukemia cell line. This mutant isogenic line was generated using the CRISPR/Cas9 system followed by single cell cloning and validation.

Date Created10/03/2017 12:01 PM
Date Updated10/03/2017 12:02 PM

Most Popular Answers

  1. Huh7 cell line
  2. ATCC HUVEC lines
  3. Passage number vs. population doubling level (PDL)
  4. Converting TCID[50] to plaque forming units (PFU)
  5. U-373 MG (ATCC® HTB-17)